Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Chemotherapy for colorectal cancers].

A Lièvre1, E Mitry

  • 1Fédération des Spécialités Digestives, Hôpital Ambroise Paré--Boulogne.

Journal De Chirurgie
|April 24, 2003
PubMed
Summary

Chemotherapy improves survival for colorectal cancer (CRC) patients. Newer regimens like FOLFIRI and FOLFOX show better response and survival rates than standard 5-FU/Leucovorin, especially in metastatic cases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Survival outcomes in POD1UM-303/InterAACT-2: a phase 3 study of retifanlimab plus carboplatin-paclitaxel in first-line advanced squamous anal cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same author

Intrahepatic cholangiocarcinoma trends and treatment lines: real-world evidence from the French National Hospital Discharge database.

ESMO gastrointestinal oncology·2026
Same author

Effect of 5 years of CT-scan and CEA follow-up on survival endpoints in patients with colorectal cancer: the PRODIGE-13 FFCD phase III trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Proof of concept and design of an externally controlled trial for patients with gastro-enteropancreatic neuroendocrine carcinomas based on the randomized phase II BEVANEC trial.

European journal of cancer (Oxford, England : 1990)·2025
Same author

High-grade intraepithelial lesions of the anus-patience: A road to wisdom.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2025
Same author

Development and validation of AI-assisted transcriptomic signatures to personalize adjuvant chemotherapy in patients with pancreatic ductal adenocarcinoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2024

Area of Science:

  • Oncology
  • Gastroenterology
  • Public Health

Background:

  • Colorectal cancer (CRC) is a leading cause of cancer death in France.
  • Adjuvant chemotherapy improves outcomes for Stage III CRC post-resection.
  • Palliative chemotherapy enhances survival and quality of life for metastatic CRC patients.

Purpose of the Study:

  • To review current chemotherapy strategies for colorectal cancer.
  • To evaluate the efficacy of novel chemotherapy regimens.
  • To highlight the importance of early diagnosis and multidisciplinary approaches.

Main Methods:

  • Review of adjuvant and palliative chemotherapy protocols for CRC.
  • Comparison of 5-FU/Leucovorin with irinotecan (FOLFIRI) and oxyplatin (FOLFOX) regimens.
  • Discussion of ongoing research in drug development and treatment strategies.

Main Results:

  • FOLFIRI and FOLFOX demonstrate superior tumor response and survival rates compared to 5-FU/Leucovorin.
  • Effective palliative chemotherapy can enable secondary resection of hepatic metastases.
  • Despite advances, 5-year survival remains suboptimal at 40%.

Conclusions:

  • Optimizing chemotherapy protocols and exploring new drugs are crucial for improving CRC outcomes.
  • Early diagnosis through systematic screening is essential for increasing curative resection feasibility.
  • Multidisciplinary management is key for treating advanced colorectal cancer.

Related Experiment Videos